The Effects of Aspirin and Clopidogrel Response on Myonecrosis After Percutaneous Coronary Intervention. A BRIEF-PCI (Brief Infusion of Intravenous Eptifibatide Following Successful Percutaneous Coronary Intervention) Trial Substudy

JACC: Cardiovascular Interventions

Volumn 1, Issue 6, 2008, Pages 654-659

  Saw, Jacqueline ^a   Densem, Cameron ^a   Walsh, Simon ^a   Jokhi, Percy ^a   Starovoytov, Andrew ^a   Fox, Rebecca ^a   Wong, Graham ^a   Buller, Christopher ^a   Ricci, Donald ^a   Mancini, G B John ^a   Fung, Anthony ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

aspirin; clopidogrel; PCI; resistance

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENOXAPARIN; EPTIFIBATIDE; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG INFUSION; DRUG RESPONSE; FEMALE; HUMAN; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MUSCLE NECROSIS; PERCUTANEOUS CORONARY INTERVENTION; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE AGGREGATION INHIBITION; THROMBOSIS;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ASPIRIN; BLOOD PLATELETS; CORONARY ARTERY DISEASE; DRUG ADMINISTRATION SCHEDULE; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; FEMALE; HEART DISEASES; HEMORRHAGE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NECROSIS; PEPTIDES; PLATELET AGGREGATION INHIBITORS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; PROSPECTIVE STUDIES; TICLOPIDINE; TIME FACTORS; TREATMENT OUTCOME;

EID: 57549088826     PISSN: 19368798     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcin.2008.08.017     Document Type: Article

References (9)

1. Chen W.H., Lee P.Y., Ng W., Tse H.F., and Lau C.P. Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatment. J Am Coll Cardiol 43 (2004) 1122-1126
2. Lev E.I., Patel R.T., Maresh K.J., et al. Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention: the role of dual drug resistance. J Am Coll Cardiol 47 (2006) 27-33
3. Buch A.N., Singh S., Roy P., et al. Measuring aspirin resistance, clopidogrel responsiveness, and postprocedural markers of myonecrosis in patients undergoing percutaneous coronary intervention. Am J Cardiol 99 (2007) 1518-1522
4. Fung AY, Saw J, Starovoytov A, et al. Brief infusion of eptifibatide following PCI. Presented at: 2007 Scientific Sessions of the American Heart Association; November 4-7, 2007, Orlando, FL.
5. Lincoff A., Bittl J., Harrington R., et al. Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention. JAMA 289 (2003) 853-863
6. van 't Hof A.W., Liem A., Suryapranata H., Hoorntje J.C., de Boer M.J., and Zijlstra F. Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Zwolle Myocardial Infarction Study Group. Circulation 97 (1998) 2302-2306
7. Lordkipanidze M., Pharand C., Schampaert E., Turgeon J., Palisaitis D.A., and Diodati J.G. A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease. Eur Heart J 28 (2007) 1702-1708
8. McGlasson D.L., and Fritsma G.A. Comparison of four laboratory methods to assess aspirin sensitivity. Blood Coagul Fibrinolysis 19 (2008) 120-123
9. Paniccia R., Antonucci E., Gori A.M., et al. Different methodologies for evaluating the effect of clopidogrel on platelet function in high-risk coronary artery disease patients. J Thromb Haemost 5 (2007) 1839-1847